Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
1.860
-0.120 (-6.06%)
At close: Dec 5, 2025, 4:00 PM EST
1.920
+0.060 (3.23%)
After-hours: Dec 5, 2025, 7:31 PM EST
Acumen Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -133.35 | -102.33 | -52.37 | -42.86 | -100.61 | -7.33 | |
| Depreciation & Amortization | 0.18 | 0.18 | 0.18 | 0.17 | 0 | - | |
| Asset Writedown & Restructuring Costs | - | - | 0.74 | - | - | - | |
| Loss (Gain) From Sale of Investments | -1.35 | -5.11 | -3.13 | 0.49 | 0.16 | - | |
| Stock-Based Compensation | 9.78 | 9.64 | 6.15 | 3.06 | 0.92 | 0.15 | |
| Other Operating Activities | 0.98 | -0.24 | 1.51 | - | 81.27 | -0.59 | |
| Change in Accounts Receivable | - | - | - | - | - | -0.08 | |
| Change in Accounts Payable | -1.66 | 4.27 | -0.26 | 0.55 | 0.56 | 0.31 | |
| Change in Other Net Operating Assets | 1.77 | 7.38 | 4.13 | 3.43 | -0.26 | 0.08 | |
| Operating Cash Flow | -123.66 | -86.22 | -43.06 | -35.15 | -17.96 | -7.45 | |
| Capital Expenditures | -0.09 | -0.02 | -0.02 | -0.16 | -0.04 | - | |
| Sale of Property, Plant & Equipment | - | - | 0 | - | - | - | |
| Investment in Securities | 137.43 | 48.04 | -171.65 | 39.35 | -104.08 | - | |
| Investing Cash Flow | 137.35 | 48.03 | -171.67 | 39.19 | -104.12 | - | |
| Long-Term Debt Issued | - | - | 30 | - | - | - | |
| Long-Term Debt Repaid | - | -0.74 | - | - | - | - | |
| Net Debt Issued (Repaid) | - | -0.74 | 30 | - | - | - | |
| Issuance of Common Stock | 0.04 | 7.94 | 122.23 | 3.91 | 169.19 | - | |
| Repurchase of Common Stock | -0.08 | -0.04 | - | - | - | - | |
| Other Financing Activities | - | -0.23 | -0.48 | - | - | - | |
| Financing Cash Flow | -0.05 | 6.93 | 151.75 | 3.91 | 200.47 | 44.68 | |
| Net Cash Flow | 13.64 | -31.26 | -62.98 | 7.94 | 78.39 | 37.23 | |
| Free Cash Flow | -123.75 | -86.23 | -43.09 | -35.31 | -18 | -7.45 | |
| Free Cash Flow Margin | - | - | - | - | - | -518.80% | |
| Free Cash Flow Per Share | -2.05 | -1.44 | -0.89 | -0.87 | -0.90 | -17.77 | |
| Cash Interest Paid | 2.94 | 2.97 | 0.17 | - | - | - | |
| Levered Free Cash Flow | -78.96 | -52.29 | -28.24 | -20.94 | -16.35 | 0.21 | |
| Unlevered Free Cash Flow | -76.35 | -49.75 | -27.87 | -20.94 | -16.35 | 0.21 | |
| Change in Working Capital | 0.11 | 11.65 | 3.87 | 3.99 | 0.3 | 0.31 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.